Cell-based therapy specialist Solentim expands European operations

The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within the EU

Solentim, the specialist in workflows for antibody and cell-based therapies, has announced an expansion of its European operations.

The company has established a new EU entity based in Ireland to facilitate frictionless business within the EU. Additionally, Solentim has opened a new warehousing and logistics hub in Germany to better serve its customers within the EU.

"Europe is a fast-growing part of our business both in our core therapeutic antibody business and in new development areas including cell and gene therapies," said Solentim's CEO, Dr Mark Truesdale. "This changing therapeutic landscape, in addition to our launch of two major new products, has rapidly increased demand. We want to be closer and more responsive to the needs of the European market and our office in Ireland will ensure ease of operation for customers while our new warehouse facility in Germany will mean that we can deliver products more quickly and easily."

Solentim recently announced the launch of two major products, the award winning ICON benchtop system and STUDIUS data management system.

Companies